Silo Pharma Files Patent Application for Alzheimer's Drug SPC-14 Targeting Novel Mechanism of Action
Silo Pharma, Inc. has announced the filing of a patent application for its neurology drug, SPC-14, which is an intranasal treatment for Alzheimer's disease. This compound, licensed from Columbia ...
Rockville, MD—Recent discoveries by researchers at the Uniformed Services University of the Health Sciences (USU) could lead to new avenues of exploration for radioprotection in diverse settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results